Stoke Therapeutics, Inc. · NASDAQ:STOK
Ticho Barry sold 2,243 Stoke Therapeutics, Inc. shares (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 2,243 Stoke Therapeutics, Inc. shares at US$32.79 for US$73,548 under a trading plan, leaving 36,621 shares. Filed May 5, 2026 (Form 4).
- Sold
- 2,243 shares
- Price
- US$32.79
- Value
- US$73,548
- Holding after
- 36,621 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Sale | 2,243 | US$32.79 | 36,621 | Direct |
Source
Related
- Stoke Therapeutics, Inc.
- Ticho Barry
- Stoke Therapeutics, Inc. shareholders
- Form 4 · Ticho Barry · Oct 2, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026
- Form 4 · Ticho Barry · Aug 5, 2026
- Form 4 · Ticho Barry · Jul 6, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Kaye Edward M. MD · Aug 18, 2026
- Form 4 · Allan Jonathan · Aug 18, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026